| Safety and Sustainability o Continuous excellent safety result: Q3 2026 TRIR landed at 0.065, process safety on good track o Sustainability: continuous improvement in sustainability performance Q3 2026: Adisseo recorded a double-digit revenue growth (+26% yoy, CNY5.57 billion), with gross profit increased (+59% yoy, CNY1.88 billion), driven by: o Outstanding quarter in methionine, thanks to very strong operational excellence, effective price management and continuous market expansion, offsetting negative impact from raw materials o Continued solid revenue growth in specialties at constant FX level with improved gross margin level as a result from effective implementation of performance improvement plan Key projects on track o 150KT powder methionine plant and DSA project in Quanzhou: construction in final stage, now under commissioning preparation as well as sales preparation o 30KT Debottlenecking in Nanjing plant: design and construction on track as planned with equipment contracts signed o R&I Projects on track, with constructions expected to complete in 2027: o Biotech pilot platforms in France allowing Adisseo to accelerate the development of biotech-based products o Advanced Chemical Pilot R&D Platform in China reinforcing the capacity to optimize chemistry process o Project to internalize the esterification process to produce the key ruminant product in Burgos plant: Test on partial downstream line successfully performed, optimization work in progress to meet higher safety standards o Nanjing plant wastewater treatment project: operation condition almost achieved with continuous improvement on-going One-China Strategy recorded strong double-digit revenue growth in Q3 2026 thanks to: o Continued double-digit growth in methionine o Solid growth in specialties business, a success of “local for local” strategy, driven by: o strong growth in monogastric contributed by local customized products in feed integrity and animal resilience o rebounding ruminant business thanks to the recovering dairy market in China o Nanjing plant running at high speed with excellent reliability FY2026 outlook o Safety and sustainability remain Adisseo’s top priorities o Volatility and uncertainty are prevailing, while market demand is expected to remain solid o Adisseo is fully engaged in leveraging its global operational and sales footprint and operational excellence to address customer demands and to deliver its profitability objectives |
LI Bo, Chairman of Adisseo, said: “We delivered an outstanding performance in the third quarter, with net profit surging +204% yoy, alongside a meaningful expansion in net profit margin and continued strong growth in revenue and gross profit. The combination of top-line growth, operational excellence and improved profitability reflects our focus on operational execution, competitiveness enhancement, and financial discipline.
Celebrating its 20th anniversary of Adisseo belonging to Sinochem family in 2026, the company has delivered impressive outstanding achievements. These remarkable accomplishments are the best proof of our two decades of persistent efforts, professional dedication, and steady development. ‘One Vision, Two Cultures, Twenty Years of Success’ has laid a solid foundation for our future high-quality development.
Looking ahead, we will continue to build on this momentum, invest in innovations, pursue attractive growth opportunities and strengthen our operating efficiency to support sustainable business growth and long-term competitiveness.”
Bluestar Adisseo Company (“Adisseo” or “the Company”) board of directors disclosed its Q3 2026 report.
I. Business Review: Revenues & Net Profit Attributable to Shareholders
| Unit: CNY billion | Q3 2026 | Q3 2025 | YoY variance | Q3 YTD 2026 | Q3 YTD 2025 | YoYvariance |
| Operating revenue | 5.57 | 4.42 | +26% | 15.28 | 12.93 | +18% |
| - Performance Products | 4.43 | 3.28 | +35% | 11.77 | 9.75 | +21% |
| - Specialty Products | 1.14 | 1.14 | +0% | 3.51 | 3.18 | +10% |
| Gross profit(in % of operating revenue) | 1.88 34% | 1.19 27% | +59% +7ppt | 4.63 30% | 3.60 28% | +29% +2ppt |
| - Performance Products | 1.41 | 0.76 | +85% | 3.16 | 2.35 | +34% |
| - Specialty Products | 0.47 | 0.42 | +11% | 1.47 | 1.25 | +18% |
| EBITDA(EBITDA margin) | 1.42 26% | 0.81 18% | +76% +8ppt | 3.44 23% | 2.65 20% | +30% +3ppt |
| Net profit attributable to shareholders (Net margin) | 0.76 14% | 0.25 6% | +204% +8ppt | 1.67 11% | 0.99 8% | +68% +3ppt |
| Recurring net profit attributable to shareholders (Recurring Net margin) | 0.76 14% | 0.24 6% | +212% +8ppt | 1.67 11% | 0.99 8% | +70% +3ppt |
Safety is and will remain Adisseo’s priority. Continuous excellent safety results have been achieved in Q3 2026 with TRIR landed at 0.065 and process safety on good track.
Continuous improvement in sustainability performance has been pursued with GHG emission and energy & water consumption continued to improve thanks to high production level of plants and implementation of strategic environmental projects.
As an illustration, the Nanjing plant wastewater treatment project achieved normal operation conditions, entering a continuous improvement stage.
The company’s corporate sustainability ambition has been pursued with SD Roadmap 2025-2030 updated and dedicated reporting & ESG Ratings tasks underway to better link ESG risks to financial impacts.
In Q3 2026, Adisseo recorded a double-digit revenue growth (+26% yoy, CNY5.57 billion)/QoQ (+5%), with gross profit increased (+59% yoy, CNY1.88 billion)/QoQ (+15%), driven by:
§ Outstanding quarter in methionine, thanks to very strong operational excellence, effective price management and continuous market expansion, offsetting negative impact from raw materials
§ Solid revenue growth in specialties at constant FX level with improved gross margin level as a result from effective implementation of performance enhancement plan
Q3 2026 is an outstanding quarter for the methionine business with best revenue record thanks to
§ Pricing management thanks to global sales & marketing network and its capability to manage pricing fluctuation vs cost increase in different regions
§ Robust volume growth
§ High plant reliability in Nanjing plant and Roussillon plant
§ Positive contribution from by-product
§ Offsetting negative impact arising from raw materials and disruption in European plants due to transportation restriction
The new 150KT powder methionine plant and DSA project in Quanzhou has its construction in the final stage and is currently under commissioning preparation as well as sales preparation.
The design and construction of the 30KT Debottlenecking project in Nanjing Plant is on track as planned with main equipment contracts signed.
Vitamins business is under pressure but is being managed in the most agile and lean manner:
§ For vitamin A: rebound on volume but with depressed market price. However, VA cost optimization project is well on track
§ Resilient results on VE and Portfolio and is expected to be improved thanks to the optimizing of the sourcing strategy
In Q3 2026, Specialties business delivered better-than-market revenue growth at constant FX level:
§ All Species with healthy growth momentum: 1) continuous growth in Monogastric supported by good market trend for poultry 2) outstanding Aqua performance, 3) considerable growth in Ruminants despite fierce competition environment, and 4) tangible progress achieved in pet business.
§ Product line wise, double-digit growth in both Feed Integrity& Quality line (Palatability and Mycotoxin Management) and in Animal Resilience line led by Alterion, Selisseo and Farm Care, and continued double-digit growth in Protected Amino-acid
§ Innovation effect contributes to the acceleration with more to come thanks to the successful launch of new products in 2026
§ Good progress on profitability and strategy execution: price increases in main products, profitability improvement enhancement plans and fixed costs management
R&I Projects are on track with constructions expected to complete in 2027:
§ Biotech pilot platforms in France enabling Adisseo to accelerate the development of biotech-based products
§ Advanced Chemical Pilot R&D Platform in China reinforcing its capacity to optimize chemistry process
The project to internalize esterification process to produce the key ruminant product in Burgos plant performed test on its partial downstream lines successfully. Follow-on improvement projects are performed to meet higher safety standards.
Adisseo achieved broad-based revenue growth across its major geographic markets in the third quarter. Thanks to the global set-up of the company, the positive impact from the agile management of geopolitical tension in the Middle East has been reflected in the results.
One-China Strategy recorded strong double-digit revenue growth in Q3 2026 thanks to:
· Continued strong growth in methionine
· Solid growth in specialties business, a success of “local for local” strategy, mainly contributed by strong growth in monogastric driven by local customized products in feed integrity and animal resilience as well as rebounding ruminant business thanks to the recovering dairy market in China
· Nanjing plant is running at a high speed with excellent reliability.
In Q3 2026, EBITDA ratio landed at 26%, a strong improvement of +8ppt compared with last year.
Net profit attributable to shareholders in Q3 2026 stood at CNY762 million, with a significant increase of +204% yoy, representing an improved net margin of 14%.
II. Cash-flow and Net Debt
Cash position as of 30 September 2026 increased compared to 31 December 2025, driven by:
§ Positive cash flow generated from operating activities
§ Increased low-cost financing in China for the 150KT powder methionine plant
§ Consumed by continuous CAPEX investment for future growth and dividend payment as well as increased working capital due to price & cost increase as well as preparation for technical shut-down in Q4 for Nanjing plant
III. Capital Market Activities Update
New Chairman was on board in September 2026 and will concurrently hold the role of CEO since 1st November. His industrial expertise, strategic vision, and deep understanding of Adisseo’s shareholder ecosystem position him well to lead the company as it strengthens its global leadership, solidify “WE” culture and accelerates its high-quality development.
In strict compliance with the “Three Majors and One Large” decision-making requirements, the Articles of Association (AOA), the Rules of Procedure for the Shareholders’ Meeting and the Board of Directors, and other related corporate governance polices have been revised, further strengthening the company’s governance framework and enhancing its compliance and completeness.
IV. FY2026 Outlook
Sustainability and safety will remain Adisseo’s top priorities.
Volatility and uncertainty are prevailing in the context of increasing geopolitical pressure.
In Q4, it is expected to have downward price trend in some regions and start of decrease of some raw material, However, market demand is expected to remain solid, especially in poultry, in a highly competitive environment with new methionine capacities entering the market. Adisseo is fully engaged in leveraging its global operational and sales footprint and operational excellence to address customer demands and deliver its profitability target.
Solid operational dynamics is being pursued with:
§ Expanded methionine production capacity coupled with robust plant operational efficiency across plants as well as the new powder capacities allowing to pursue volume growth in methionine
§ Continuous proactive pricing management in methionine
§ Production platforms in China and Europe allowing to agile global supply to ensure maximization of profitability
§ Competitiveness enhancement programs particularly in less performing plants and businesses
§ Acceleration of specialties dynamics with proactive pricing and portfolio management to drive profitability and on-schedule launching of new products to boost growth
While continuing to invest in the future through:
§ Reinforced of Research & Innovation efforts, including establishment of industry pilots in both China and Europe, allowing delivering continuous process improvement and sustainable & innovative products solutions
§ Acceleration of digitization leveraging AI capabilities